PRESENTATIONS 6:18 Prof Paddy Mark – All hail kale: Vitamin K trials in Chronic Kidney Disease 34:20 Dr Jennifer Lees – The impact of age, sex, comorbidity count and race on attrition and screen failure from trials 58:19 Dr Nicole De La Mata – Sex… Read More »Equality and Evidence Integration in Kidney Disease; Sex and Multimorbidity – Symposium
From left: Rachel Cutting, Juliet Byrnes, Brenda Rosales, Nicole De La Mata, Pinika Patel, James Hedley, Laia Oliveras-Pages
SHE-ROCKS is a collaborative project between CODE at the University of Sydney and researchers at the University of Glasgow, and is supported by a University of Sydney- University of Glasgow Partnership Collaboration Award 2022. We know females have poorer outcomes than males in kidney failure… Read More »SHE-ROCKS – Sex and Health; Evaluating diagnosis, Risk factOrs and Complications in chronic Kidney disease
The Mental Health Living Longer (MHLL) programme established a population-wide data linkage to support research translation and service reform for mental health in New South Wales (NSW), Australia (learn more about it here: Mental Health Living Longer (MHLL) protocol ). In partnership with the MHLL… Read More »ASSET NSW- AcceSS and Equity in Kidney Disease and Transplantation: impact of severe and persistent mental illness, New South Wales
The I-MAGICK study uses data linkage to evaluate the health service delivery for people with advanced chronic kidney disease (CKD) affected by multimorbidity, including cardiovascular disease and mental health conditions. We are developing evidence to improve equitable delivery of health care and services, including cardiovascular… Read More »I-MAGICK – Improving health MAnaGement In people with advanced Chronic Kidney disease
Relative survival provides a more reliable measure of excess mortality for people diagnosed with cancer. In the general population with cancer, the relative survival has increased to 68% in 2009-13 but estimates for the kidney failure and kidney transplant population with cancer are unknown. ReSKiTE… Read More »ReSKiTE – Relative Survival from cancer in Kidney Transplant recipients and people with End-stage kidney disease in Australia and New Zealand
After organ transplantation, infections, including common communicable infections such as influenza, frequently cause disease, although the actual amount of infection and disease is unclear. We aimed to measure the burden of notifiable infectious diseases in an Australian cohort of transplant recipients compared with the general… Read More »Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000–2015
Potential organ donors with primary brain tumours (PBT) frequently donate, however some may be declined due to uncertainty about tumour classification or transmission risk to transplant recipients. We sought to describe transmission risk and donation outcome of potential donors with PBT, including identifying missed opportunities… Read More »Potential organ donors with primary brain tumours: missed opportunities for donation and transplantation identified in Australian cohort study 2010–2015
Dr Brenda Rosales presented “the impact of sex and gender on equity and access to cancer care for kidney transplant recipients”. Conference held from 5 October 2022 to 7 October 2022.
Laia Oliveras, is a Nephrology trainee at Hospital Universitari de Bellvitge, in Barcelona. She is interested in glomerular diseases, kidney transplant and Clinical Epidemiology. She is currently visiting and collaborating with the CODE team at the University of Sydney.